Breath Tests for Smoking: Understanding CO Monitoring and Honesty in Care

Carbon monoxide (CO) breath testing is a non‑invasive, point‑of‑care tool that measures recent tobacco smoke exposure. Exhaled CO (parts per million) correlates with carboxyhemoglobin levels and cigarette consumption in the prior 12–24 hours.

Clinical Use

• Smoking cessation programs: Objective biomarker for self‑report validation; motivational feedback.
• Prenatal care: Identifies active smoking; guides intervention.
• Preoperative assessment: High CO predicts perioperative pulmonary complications.
• Research: Standardized adherence metric.

Limitations

• Short half‑life (~4–6 hrs); misses earlier smoking.
• Environmental CO (traffic, faulty heaters) can elevate baseline.
• E‑cigarettes/vaping produce negligible CO; not detected.
• Cannot distinguish tobacco from other combustion sources.

Ethical Note

Attempting to “beat” the test (e.g., breath‑holding, hyperventilation) undermines the therapeutic alliance. Honest disclosure enables tailored counseling, pharmacotherapy (NRT, varenicline, bupropion), and referral—maximizing quit success. Clinicians are partners, not police.